Anti-androgens with full antagonistic activity toward human prostate tumor LNCaP cells with mutated androgen receptor.
Тип публикации: Journal Article
Дата публикации: 2003-08-01
scimago Q2
wos Q2
БС2
SJR: 0.472
CiteScore: 5.1
Impact factor: 2.2
ISSN: 0960894X, 14643405
PubMed ID:
12873487
Organic Chemistry
Drug Discovery
Biochemistry
Molecular Biology
Pharmaceutical Science
Clinical Biochemistry
Molecular Medicine
Краткое описание
Anti-androgens were designed based on the principle of inhibiting the folding of helix 12 of the nuclear androgen receptor. The prepared anti-androgens exhibited full antagonistic activity toward human prostate tumor LNCaP cells with T877A point-mutated nuclear androgen receptor, as far as examined, towards which other known anti-androgens, including hydroxyflutamide, are inactive or act as androgen agonists.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.
Топ-30
Журналы
|
1
2
3
4
5
6
7
8
|
|
|
Bioorganic and Medicinal Chemistry
8 публикаций, 8.7%
|
|
|
Research on Chemical Intermediates
7 публикаций, 7.61%
|
|
|
Bioorganic and Medicinal Chemistry Letters
6 публикаций, 6.52%
|
|
|
Organic and Biomolecular Chemistry
4 публикации, 4.35%
|
|
|
ChemistrySelect
3 публикации, 3.26%
|
|
|
Chemical and Pharmaceutical Bulletin
3 публикации, 3.26%
|
|
|
Organic Preparations and Procedures International
3 публикации, 3.26%
|
|
|
Journal of Molecular Structure
3 публикации, 3.26%
|
|
|
European Journal of Medicinal Chemistry
3 публикации, 3.26%
|
|
|
Angewandte Chemie
3 публикации, 3.26%
|
|
|
Angewandte Chemie - International Edition
3 публикации, 3.26%
|
|
|
Journal of Medicinal Chemistry
3 публикации, 3.26%
|
|
|
Current Organic Chemistry
2 публикации, 2.17%
|
|
|
MolBank
2 публикации, 2.17%
|
|
|
Tetrahedron
2 публикации, 2.17%
|
|
|
Tetrahedron Letters
2 публикации, 2.17%
|
|
|
Journal of Heterocyclic Chemistry
2 публикации, 2.17%
|
|
|
European Journal of Organic Chemistry
2 публикации, 2.17%
|
|
|
Synthetic Communications
2 публикации, 2.17%
|
|
|
Bioorganic Chemistry
2 публикации, 2.17%
|
|
|
Mendeleev Communications
1 публикация, 1.09%
|
|
|
Current Green Chemistry
1 публикация, 1.09%
|
|
|
Yakugaku Zasshi
1 публикация, 1.09%
|
|
|
Anti-Cancer Drugs
1 публикация, 1.09%
|
|
|
Scientific Reports
1 публикация, 1.09%
|
|
|
Iranian Journal of Science and Technology, Transaction A: Science
1 публикация, 1.09%
|
|
|
Silicon
1 публикация, 1.09%
|
|
|
Journal of Chemical Sciences
1 публикация, 1.09%
|
|
|
PLoS ONE
1 публикация, 1.09%
|
|
|
1
2
3
4
5
6
7
8
|
Издатели
|
5
10
15
20
25
30
|
|
|
Elsevier
27 публикаций, 29.35%
|
|
|
Wiley
16 публикаций, 17.39%
|
|
|
Springer Nature
11 публикаций, 11.96%
|
|
|
American Chemical Society (ACS)
6 публикаций, 6.52%
|
|
|
Royal Society of Chemistry (RSC)
6 публикаций, 6.52%
|
|
|
Taylor & Francis
5 публикаций, 5.43%
|
|
|
Bentham Science Publishers Ltd.
4 публикации, 4.35%
|
|
|
Pharmaceutical Society of Japan
4 публикации, 4.35%
|
|
|
MDPI
3 публикации, 3.26%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 публикация, 1.09%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 1.09%
|
|
|
Public Library of Science (PLoS)
1 публикация, 1.09%
|
|
|
The Japan Institute of Heterocyclic Chemistry
1 публикация, 1.09%
|
|
|
Walter de Gruyter
1 публикация, 1.09%
|
|
|
American Association for Cancer Research (AACR)
1 публикация, 1.09%
|
|
|
Georg Thieme Verlag KG
1 публикация, 1.09%
|
|
|
Hindawi Limited
1 публикация, 1.09%
|
|
|
5
10
15
20
25
30
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
92
Всего цитирований:
92
Цитирований c 2025:
4
(4.35%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
ISHIOKA T. et al. Anti-androgens with full antagonistic activity toward human prostate tumor LNCaP cells with mutated androgen receptor. // Bioorganic and Medicinal Chemistry Letters. 2003. Vol. 13. No. 16. pp. 2655-2658.
ГОСТ со всеми авторами (до 50)
Скопировать
ISHIOKA T., Tanatani A., Nagasawa K., HASHIMOTO Y. Anti-androgens with full antagonistic activity toward human prostate tumor LNCaP cells with mutated androgen receptor. // Bioorganic and Medicinal Chemistry Letters. 2003. Vol. 13. No. 16. pp. 2655-2658.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1016/S0960-894X(03)00575-4
UR - https://doi.org/10.1016/S0960-894X(03)00575-4
TI - Anti-androgens with full antagonistic activity toward human prostate tumor LNCaP cells with mutated androgen receptor.
T2 - Bioorganic and Medicinal Chemistry Letters
AU - ISHIOKA, Toshiyasu
AU - Tanatani, Aya
AU - Nagasawa, K.
AU - HASHIMOTO, Yuichi
PY - 2003
DA - 2003/08/01
PB - Elsevier
SP - 2655-2658
IS - 16
VL - 13
PMID - 12873487
SN - 0960-894X
SN - 1464-3405
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2003_ISHIOKA,
author = {Toshiyasu ISHIOKA and Aya Tanatani and K. Nagasawa and Yuichi HASHIMOTO},
title = {Anti-androgens with full antagonistic activity toward human prostate tumor LNCaP cells with mutated androgen receptor.},
journal = {Bioorganic and Medicinal Chemistry Letters},
year = {2003},
volume = {13},
publisher = {Elsevier},
month = {aug},
url = {https://doi.org/10.1016/S0960-894X(03)00575-4},
number = {16},
pages = {2655--2658},
doi = {10.1016/S0960-894X(03)00575-4}
}
Цитировать
MLA
Скопировать
ISHIOKA, Toshiyasu, et al. “Anti-androgens with full antagonistic activity toward human prostate tumor LNCaP cells with mutated androgen receptor..” Bioorganic and Medicinal Chemistry Letters, vol. 13, no. 16, Aug. 2003, pp. 2655-2658. https://doi.org/10.1016/S0960-894X(03)00575-4.